In conclusion, this study shows the existence of a high prevalence of GH-IGF-1 dysfunction in patients with both FM and obesity, presumably as a consequence of the obese rather than fibromyalgic condition. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.